EyePoint (EYPT) EPS (Basic) (2010 - 2026)
EyePoint (EYPT) posted EPS (Basic) of -$1397.7 for Q1 2026, down 51.43% sequentially from -$922.98 in Q4 2025, and down 185941.2% YoY from N/an in Q1 2025.
Powered by 
Analysis
EyePoint (EYPT) EPS (Basic) (2010 - 2026) Analysis & Trends
EyePoint has reported EPS (Basic) for 17 years, with the latest figure at -$1397.7 in Q1 2026.
- Quarterly EPS (Basic) fell 185941.2% year-over-year to -$1397.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3569.4 (down 161606.03% YoY) and the FY2025 annual result came in at -$3166.7, down 36.22% from the prior year.
- EPS (Basic) fell to -$1397.7 in Q1 2026 per EYPT's latest filing, from -$922.98 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.44 in Q4 2023 and troughed at -$1853.8 in Q1 2024.
- A 5-year average of -$389.53 and a median of -$1.19 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) tumbled 311392.02% in 2024, then soared 99.96% in 2025.
- Over 5 years, EPS (Basic) stood at -$1.19 in 2022, then soared by 63.23% to -$0.44 in 2023, then slumped by 168401.83% to -$735.35 in 2024, then declined by 25.51% to -$922.98 in 2025, then slumped by 51.43% to -$1397.7 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1397.7, -$922.98, and -$851.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | -1.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.09 |
| Mar 31, 2026 | -1.02 |
| Dec 31, 2025 | -0.92 |
| Sep 30, 2025 | -0.85 |
| Jun 30, 2025 | -0.85 |
| Mar 31, 2025 | -0.70 |
| Dec 31, 2024 | -0.74 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.58 |
| Mar 31, 2024 | -0.63 |
| Dec 31, 2023 | -0.42 |
| Sep 30, 2023 | -0.38 |
| Jun 30, 2023 | -0.62 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -1.19 |
| Sep 30, 2022 | -0.51 |
| Jun 30, 2022 | -0.53 |
| Mar 31, 2022 | -0.52 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | -0.58 |